RESUMO
As an important Chinese medicinal material in China, Paridis Rhizoma has obvious curative effect and has analgesic, hemostasis, anti-inflammatory and anti-tumor activities. At present, it is the main raw material of 262 kinds of Chinese patent medicines such as Yunnan Baiyao and Gongxuening Capsule, and has important economic and social value in the Chinese medicine industry. The author mainly systematically summarizes the medicinal history and origin changes of Paridis Rhizoma, the history of industrial development, the status quo of ethnic and folk applications, the status quo of development and application of proprietary Chinese medicines, and the study of resource ecology and breeding, and proposes the implementation of the process of industrialization of Paridis Rhizoma. Important issues and countermeasures need to be paid attention in order to provide reference for the sound development of Paridis Rhizoma.
RESUMO
In recent years, the industry of Bletillae Rhizoma has developed rapidly and widely in medicine, health care, beauty, etc., but there are still problems that restrict its sustainable development. Based on field investigating in development status of Bletillae Rhizoma market and industry, consulting relevant literature and our research results, and main constraints were discovered as follows: wild resources shortage, uneven varieties, unclear mechanism, low comprehensive utilization, unclear quality standards, difficulty of quality control, weak industrial level, slow cluster development and so on. Therefore, we can strengthen the protection of germplasm resources and selection of superior varieties, carry out the mechanism of its effective ingredients, improve quality evaluation system and expand sales market using brand strategy to promote the healthy and sustainable development of Bletillae Rhizoma.